Skip to main content
Premium Trial:

Request an Annual Quote

Biochip Firm Lumera Registers for IPO; Stands to Gain $28 Million

NEW YORK, May 28 (GenomeWeb News) - Lumera, a majority owned subsidiary of Microvision, has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering of 5 million shares of its common stock.

 

The move might net the company as much as $28 million based on pricing of between $5 to $6 a share. Lumera, which makes antennas for wireless communications and biochips, plans to trade on the Nasdaq SmallCap Market.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.